Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lora McClain is active.

Publication


Featured researches published by Lora McClain.


Schizophrenia Bulletin | 2015

Persistent Infection by HSV-1 Is Associated With Changes in Functional Architecture of iPSC-Derived Neurons and Brain Activation Patterns Underlying Working Memory Performance

Leonardo D'Aiuto; Konasale M. Prasad; Catherine H. Upton; Luigi Viggiano; Jadranka Milosevic; Giorgio Raimondi; Lora McClain; Kodavali V. Chowdari; Jay A. Tischfield; Michael Sheldon; Jennifer C. Moore; Robert H. Yolken; Paul R. Kinchington; Vishwajit L. Nimgaonkar

Background: Herpes simplex virus, type 1 (HSV-1) commonly produces lytic mucosal lesions. It invariably initiates latent infection in sensory ganglia enabling persistent, lifelong infection. Acute HSV-1 encephalitis is rare and definitive evidence of latent infection in the brain is lacking. However, exposure untraceable to encephalitis has been repeatedly associated with impaired working memory and executive functions, particularly among schizophrenia patients. Methods: Patterns of HSV-1 infection and gene expression changes were examined in human induced pluripotent stem cell (iPSC)-derived neurons. Separately, differences in blood oxygenation level-dependent (BOLD) responses to working memory challenges using letter n-back tests were investigated using functional magnetic resonance imaging (fMRI) among schizophrenia cases/controls. Results: HSV-1 induced lytic changes in iPSC-derived glutamatergic neurons and neuroprogenitor cells. In neurons, HSV-1 also entered a quiescent state following coincubation with antiviral drugs, with distinctive changes in gene expression related to functions such as glutamatergic signaling. In the fMRI studies, main effects of schizophrenia (P = .001) and HSV-1 exposure (1-back, P = 1.76 × 10− 4; 2-back, P = 1.39 × 10− 5) on BOLD responses were observed. We also noted increased BOLD responses in the frontoparietal, thalamus, and midbrain regions among HSV-1 exposed schizophrenia cases and controls, compared with unexposed persons. Conclusions: The lytic/quiescent cycles in iPSC-derived neurons indicate that persistent neuronal infection can occur, altering cellular function. The fMRI studies affirm the associations between nonencephalitic HSV-1 infection and functional brain changes linked with working memory impairment. The fMRI and iPSC studies together provide putative mechanisms for the cognitive impairments linked to HSV-1 exposure.


Alzheimer Disease & Associated Disorders | 2016

Temporal Cognitive Decline Associated With Exposure to Infectious Agents in a Population-based, Aging Cohort.

Vishwajit L. Nimgaonkar; Robert H. Yolken; Tianxiu Wang; Chung-Chou H. Chang; Lora McClain; Eric McDade; Beth E. Snitz; Mary Ganguli

Background:Numerous cross-sectional studies have related exposure to neurotropic infectious agents with cognitive dysfunction in older adults, however, the temporal sequence is uncertain. Methods:In a representative, well-characterized, population-based aging cohort, we determined whether the temporal trajectories of multiple cognitive domains are associated with exposure to cytomegalovirus (CMV), Herpes Simplex virus, type 1 (HSV-1), Herpes Simplex virus, type 2 (HSV-2), or Toxoplasma gondii (TOX). Complex attention, executive functions, memory, language, and visuospatial function were assessed annually for 5 years among consenting individuals. Study entry IgG antibody titers indexing exposure to each infectious agent were examined in relation to slopes of subsequent temporal cognitive decline using multiple linear regressions adjusted for potential confounders. Results:The IgG levels for HSV-2 were significantly associated with baseline cognitive domain scores (N=1022 participants). Further, the IgG levels for HSV-2, TOX, and CMV, but not HSV-1 were significantly associated with greater temporal cognitive decline that varied by type of infection. Conclusions:Exposure to CMV, HSV-2, or TOX is associated with cognitive deterioration in older individuals, independent of general age–related variables. An increased understanding of the role of infectious agents in cognitive decline may lead to new methods for its prevention and treatment.


American Journal of Medical Genetics | 2010

Fine-mapping reveals novel alternative splicing of the dopamine transporter

Michael E. Talkowski; Kathleen L. McCann; Michael Chen; Lora McClain; Mikhil Bamne; Joel Wood; Kodavali V. Chowdari; Annie M. Watson; Konasale M. Prasad; George Kirov; Lyudmila Georgieva; Draga Toncheva; Hader Mansour; David A. Lewis; Michael John Owen; Michael Conlon O'Donovan; Panagiotis Papasaikas; Patrick F. Sullivan; Douglas M. Ruderfer; Jeffrey K. Yao; Sherry Leonard; Pramod Thomas; Fabio Miyajima; John P. Quinn; A. Javier Lopez; Vishwajit L. Nimgaonkar

The dopamine transporter gene (SLC6A3, DAT) has been implicated in the pathogenesis of numerous psychiatric and neurodevelopmental disorders, including schizophrenia (SZ). We previously detected association between SZ and intronic SLC6A3 variants that replicated in two independent Caucasian samples, but had no obvious function. In follow‐up analyses, we sequenced the coding and intronic regions of SLC6A3 to identify complete linkage disequilibrium patterns of common variations. We genotyped 78 polymorphisms, narrowing the potentially causal region to two correlated clusters of associated SNPs localized predominantly to introns 3 and 4. Our computational analysis of these intronic regions predicted a novel cassette exon within intron 3, designated E3b, which is conserved among primates. We confirmed alternative splicing of E3b in post‐mortem human substantia nigra (SN). As E3b introduces multiple in‐frame stop codons, the SLC6A3 open reading frame is truncated and the spliced product may undergo nonsense mediated decay. Thus, factors that increase E3b splicing could reduce the amount of unspliced product available for translation. Observations consistent with this prediction were made using cellular assays and in post‐mortem human SN. In mini‐gene constructs, the extent of splicing is also influenced by at least two common haplotypes, so the alternative splicing was evaluated in relation to SZ risk. Meta‐analyses across genome‐wide association studies did not support the initial associations and further post‐mortem studies did not suggest case‐control differences in splicing. These studies do not provide a compelling link to schizophrenia. However, the impact of the alternative splicing on other neuropsychiatric disorders should be investigated.


American Journal of Medical Genetics | 2009

Convergent patterns of association between phenylalanine hydroxylase variants and schizophrenia in four independent samples

Michael E. Talkowski; Lora McClain; Trina B. Allen; L. DiAnne Bradford; Monica E. Calkins; Neil B. Edwards; Lyudmila Georgieva; Rodney C.P. Go; Ruben C. Gur; Raquel E. Gur; George Kirov; Kodavali V. Chowdari; Joseph Kwentus; Paul D. Lyons; Hader Mansour; Joseph P. McEvoy; Michael Conlon O'Donovan; Judith R. O'Jile; Michael John Owen; Alberto B. Santos; Robert M. Savage; Draga Toncheva; Gerard Vockley; Joel Wood; Bernie Devlin; Vishwajit L. Nimgaonkar

Recessive mutations in the phenylalanine hydroxylase (PAH) gene predispose to phenylketonuria (PKU) in conjunction with dietary exposure to phenylalanine. Previous studies have suggested PAH variations could confer risk for schizophrenia, but comprehensive follow‐up has not been reported. We analyzed 15 common PAH “tag” SNPs and three exonic variations that are rare in Caucasians but common in African‐Americans among four independent samples (total n = 5,414). The samples included two US Caucasian cohorts (260 trios, 230 independent cases, 474 controls), Bulgarian families (659 trios), and an African‐American sample (464 families, 401 controls). Analyses of both US Caucasian samples revealed associations with five SNPs; most notably the common allele (G) of rs1522305 from case–control analyses (z = 2.99, P = 0.006). This SNP was independently replicated in the Bulgarian cohort (z = 2.39, P = 0.015). A non‐significant trend was also observed among African‐American families (z = 1.39, P = 0.165), and combined analyses of all four samples were significant (rs1522305: χ2 = 23.28, 8 d.f., P = 0.003). Results for rs1522305 met our a priori criteria for statistical significance, namely an association that was robust to multiple testing correction in one sample, a replicated risk allele in multiple samples, and combined analyses that were nominally significant. Case–control results in African‐Americans detected an association with L321L (P = 0.047, OR = 1.46). Our analyses suggest several associations at PAH, with consistent evidence for rs1522305. Further analyses, including additional variations and environmental influences such as phenylalanine exposure are warranted.


ACS Medicinal Chemistry Letters | 2016

iPSC Neuronal Assay Identifies Amaryllidaceae Pharmacophore with Multiple Effects against Herpesvirus Infections.

James McNulty; Leonardo D'Aiuto; Yun Zhi; Lora McClain; Carlos Zepeda-Velázquez; Spencer Ler; Hilary A. Jenkins; Michael B. Yee; Paolo Piazza; Robert H. Yolken; Paul R. Kinchington; Vishwajit L. Nimgaonkar

The Amaryllidaceae alkaloid trans-dihydrolycoricidine 7 and three analogues 8-10 were produced via asymmetric chemical synthesis. Alkaloid 7 proved superior to acyclovir, the current standard for herpes simplex virus, type 1 (HSV-1) infection. Compound 7 potently inhibited lytic HSV-1 infection, significantly reduced HSV-1 reactivation, and more potently inhibited varicella zoster virus (VZV) lytic infection. A configurationally defined (3R)-secondary alcohol at C3 proved crucial for efficacious inhibition of lytic HSV-1 infection.


Journal of Psychiatric Research | 2013

Dopaminergic gene polymorphisms and cognitive function in a north Indian schizophrenia cohort

Prachi Kukshal; Venkat Chowdari Kodavali; Vibhuti Srivastava; Joel Wood; Lora McClain; Triptish Bhatia; A.M. Bhagwat; Smita N. Deshpande; Vishwajit L. Nimgaonkar; B.K. Thelma

BACKGROUND Associations of polymorphisms from dopaminergic neurotransmitter pathway genes have mostly been reported in Caucasian ancestry schizophrenia (SZ) samples. As studies investigating single SNPs with SZ have been inconsistent, more detailed analyses utilizing multiple SNPs with the diagnostic phenotype as well as cognitive function may be more informative. Therefore, these analyses were conducted in a north Indian sample. METHODS Indian SZ case-parent trios (n = 601 families); unscreened controls (n = 468) and an independent set of 118 trio families were analyzed. Representative SNPs in the Dopamine D3 receptor (DRD3), dopamine transporter (SLC6A3), vesicular monoamine transporter 2 (SLC18A2), catechol-o-methyltransferase (COMT) and dopamine beta-hydroxylase (DBH) were genotyped using SNaPshot/SNPlex assays (n = 59 SNPs). The Trail Making Test (TMT) was administered to a subset of the sample (n = 260 cases and n = 302 parents). RESULTS Eight SNPs were nominally associated with SZ in either case-control or family based analyses (p < 0.05, rs7631540 and rs2046496 in DRD3; rs363399 and rs10082463 in SLC18A2; rs4680, rs4646315 and rs9332377 in COMT). rs6271 at DBH was associated in both analyses. Haplotypes of DRD3 SNPs incorporating rs7631540-rs2134655-rs3773678-rs324030-rs6280-rs905568 showed suggestive associations in both case-parent and trio samples. At SLC18A2, rs10082463 was nominally associated with psychomotor performance and rs363285 with executive functions using the TMT but did not withstand multiple corrections. CONCLUSIONS Suggestive associations with dopaminergic genes were detected in this study, but convincing links between dopaminergic polymorphisms and SZ or cognitive function were not observed.


npj Schizophrenia | 2017

Generating testable hypotheses for schizophrenia and rheumatoid arthritis pathogenesis by integrating epidemiological, genomic, and protein interaction data

Tulsi A. Malavia; Srilakshmi Chaparala; Joel Wood; Kodavali V. Chowdari; Konasale M. Prasad; Lora McClain; Anil G. Jegga; Madhavi Ganapathiraju; Vishwajit L. Nimgaonkar

Patients with schizophrenia and their relatives have reduced prevalence of rheumatoid arthritis. Schizophrenia and rheumatoid arthritis genome-wide association studies also indicate negative genetic correlations, suggesting that there may be shared pathogenesis at the DNA level or downstream. A portion of the inverse prevalence could be attributed to pleiotropy, i.e., variants of a single nucleotide polymorphism that could confer differential risk for these disorders. To study the basis for such an interrelationship, we initially compared lists of single nucleotide polymorphisms with significant genetic associations (p < 1e-8) for schizophrenia or rheumatoid arthritis, evaluating patterns of linkage disequilibrium and apparent pleiotropic risk profiles. Single nucleotide polymorphisms that conferred risk for both schizophrenia and rheumatoid arthritis were localized solely to the extended HLA region. Among single nucleotide polymorphisms that conferred differential risk for schizophrenia and rheumatoid arthritis, the majority were localized to HLA-B, TNXB, NOTCH4, HLA-C, HCP5, MICB, PSORS1C1, and C6orf10; published functional data indicate that HLA-B and HLA-C have the most plausible pathogenic roles in both disorders. Interactomes of these eight genes were constructed from protein–protein interaction information using publicly available databases and novel computational predictions. The genes harboring apparently pleiotropic single nucleotide polymorphisms are closely connected to rheumatoid arthritis and schizophrenia associated genes through common interacting partners. A separate and independent analysis of the interactomes of rheumatoid arthritis and schizophrenia genes showed a significant overlap between the two interactomes and that they share several common pathways, motivating functional studies suggesting a relationship in the pathogenesis of schizophrenia/rheumatoid arthritis.Schizophrenia and rheumatoid arthritis: Exploring the linkResearchers in the USA identify variations in eight genes that potentially confer differential risk for schizophrenia and rheumatoid arthritis. Previous studies have shown that patients with schizophrenia (and their relatives) have a reduced risk of developing rheumatoid arthritis and vice versa. Vishwajit Nimgaonkar, Madhavi Ganapathiraju and colleagues at the University of Pittsburgh compared single nucleotide variations in the genetic code that are significantly associated with these diseases. They found that the inverse risk between these disorders could be due to differences harbored in eight genes. Computational analyses of the protein interactomes of genes associated exclusively with rheumatoid arthritis and those with schizophrenia revealed common interacting partners that are known to be involved in immune and inflammatory responses, and shared disease pathways. Additional investigation of these proteins could shed further light on shared disease mechanisms.


Bioorganic & Medicinal Chemistry Letters | 2017

Discovery of potent antiviral (HSV-1) quinazolinones and initial structure-activity relationship studies

Carla E. Brown; Tiffany Kong; James McNulty; Leonardo D'Aiuto; Kelly Williamson; Lora McClain; Paolo Piazza; Vishwajit L. Nimgaonkar

The discovery of antiviral activity of 2,3-disubstituted quinazolinones, prepared by a one-pot, three-component condensation of isatoic anhydride with amines and aldehydes, against Herpes Simplex Virus (HSV)-1 is reported. Sequential iterative synthesis/antiviral assessment allowed structure-activity relationship (SAR) generation revealing synergistic structural features required for potent anti-HSV-1 activity. The most potent derivatives show greater efficacy than acyclovir against acute HSV-1 infections in neurons and minimal toxicity to the host.


Human Molecular Genetics | 2008

A network of dopaminergic gene variations implicated as risk factors for schizophrenia

Michael E. Talkowski; George Kirov; Mikhil Bamne; Lyudmila Georgieva; Gonzalo E. Torres; Hader Mansour; Kodavali V. Chowdari; Vihra Milanova; Joel Wood; Lora McClain; Konasale M. Prasad; Brian H. Shirts; Jianping Zhang; Michael C. O’Donovan; Michael John Owen; Bernie Devlin; Vishwajit L. Nimgaonkar


Bipolar Disorders | 2009

Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia

Hader Mansour; Michael E. Talkowski; Joel Wood; Kodavali V. Chowdari; Lora McClain; Konasale M. Prasad; Debra M. Montrose; Andrea Fagiolini; Edward S. Friedman; Michael H. Allen; Charles L. Bowden; Joseph R. Calabrese; Rif S. El-Mallakh; Michael A. Escamilla; Stephen V. Faraone; Mark D. Fossey; Laszlo Gyulai; Jennifer M. Loftis; Peter Hauser; Terence A. Ketter; Lauren B. Marangell; David J. Miklowitz; Andrew A. Nierenberg; Jayendra K. Patel; Gary S. Sachs; Pamela Sklar; Jordan W. Smoller; Nan M. Laird; Matcheri S. Keshavan; Michael E. Thase

Collaboration


Dive into the Lora McClain's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert H. Yolken

Johns Hopkins University School of Medicine

View shared research outputs
Top Co-Authors

Avatar

Joel Wood

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paolo Piazza

University of Pittsburgh

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hader Mansour

University of Pittsburgh

View shared research outputs
Researchain Logo
Decentralizing Knowledge